Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

计划入组 253 人 · 首次发布于 2005 年 12 月 9 日

Probiotics for Birch Pollen Allergy

计划入组 47 人 · 首次发布于 2008 年 9 月 3 日

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

首次发布于 2005 年 12 月 19 日

Silver birch pollen

Birch pollen allergen vaccine

Birch pollen allergoid (Allergopharma)

ALLERGAN MEDICAL

United States

ALLERGAN LIMITED

United Kingdom

Allergan, Inc.

United States

Mabylon Advances MY006 Peanut Allergy Treatment to Phase Ib Following Positive Safety Data

NICE Approves First-in-Class Birch Pollen Immunotherapy for Severe Hayfever on NHS

Stallergenes Greer's Staloral Birch Achieves Primary Endpoint in Pediatric Phase III Trial for Allergic Rhinoconjunctivitis